Nanozyme-mediated cascade reaction system for electrochemical detection of 1,5-anhydroglucitol
Guiyin Li,Guangxiong Wu,Jindan Huang,Bo Wang,HaiMei Li,Wei Chen,Jintao Liang,Mingxiong Tan,Zhide Zhou
DOI: https://doi.org/10.1016/j.bioelechem.2022.108204
IF: 5.76
2022-10-01
Bioelectrochemistry
Abstract:Diabetes is one of metabolic diseases affecting major human health. The early diagnosis and treatment of diabetes have significant benefits. 1,5-anhydroglucitol (1,5-AG) accurately reflects a patient’s average blood glucose level for the past 3–7 days and becomes a promising marker for real-time detection of diabetes. In this study, a novel biosensor for determination 1,5-AG is constructed using reduce graphene oxide-carboxymethylated chitosan-hemin@platinum nanocomposites (rGO-CMC-H@Pt NCs) nanozyme and pyranose oxidase (PROD) enzyme as the electrochemical biosensing platform. The rGO-CMC-H@Pt NCs nanozyme has good electro-conductibility, high specific surface area, and admirable peroxide-like catalysis effect to enhance the electrochemical response. 1,5-AG is catalyzed by PROD and produces hydrogen peroxide (H2O2), which in turn can be decomposed by rGO-CMC-H@Pt NCs and produce a current signal recorded by differential pulse voltammetry (DPV) technique. Under optimal conditions, the response currents have a linear relationship in the 1,5-AG concentration of 0.1–2.0 mg/mL with R2 of 0.9869. The sensitivity is 2.1895 μA/μg·mL−1 and the limit of detection (LOD) is 38.2 μg/mL (S/N = 3). In addition, the specificity, reproducibility, stability and recovery (94.5–107.6%) of 1,5-AG biosensors all exhibit good performance. Therefore, the designed 1,5-AG biosensor has a good effect and can be used for the diagnosis of diabetes.
biochemistry & molecular biology,electrochemistry,biology,biophysics